corgenix Message Board - Msg: 25654328

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : corgenix

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: RikRichter	5/19/2009 10:12:28 AM
	Read Replies (1) of 191

CONX.OB 0.12 - Biggest volume day in over 6 months in the first half hour of trading today. Only 30.3 Million shares outstanding giving it a market cap a mere $3.6 Million. Corgenix Medical has 52 FDA-approved products on the market yet is trading at a PSR of only 0.46. Its medical test products address autoimmune, vascular and liver diseases and CONX.OB is developing a group of products to detect potential bio-terrorism agents. It recently got a Federal grant to continue its Lassa virus test kits. Its AspirinWorks test is expected to have significant growth potential once it clears the hurdle of medical community acceptance. The company recently cleaned up its balance sheet severely cutting its interest expenses and indicated late last week that it is on the road to positive cash flow and profitability after almost breaking even in its Q3. EBITDA more than doubled in the latest quarter.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next